Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,151,961 | 2,152,278 | 1,791,665 | 3,851,314 | 3,254,394 |
| Marketable Securities | 2,547,399 | 2,229,371 | 1,932,557 | 1,932,760 | 1,698,268 |
| Receivables | 10,303,120 | 8,346,416 | 8,142,708 | 7,239,903 | 6,669,377 |
| Inventories | 4,093,722 | 3,691,122 | 3,453,341 | 3,141,937 | 3,103,958 |
| Other current assets | -2 | 3 | -1 | 6 | 3 |
| TOTAL | $20,096,200 | $16,419,190 | $15,320,270 | $16,165,920 | $14,726,000 |
| Non-Current Assets | |||||
| PPE Net | 10,961,010 | 10,089,020 | 9,440,613 | 8,610,627 | 8,516,508 |
| Investments And Advances | 216,082 | 174,505 | 190,169 | 167,637 | 177,606 |
| Intangibles | 7,414,429 | 7,275,465 | 7,280,505 | 6,348,817 | 6,376,370 |
| Other Non-Current Assets | 2,330,289 | 2,070,430 | 1,930,433 | 1,562,719 | 1,510,226 |
| TOTAL | $20,921,810 | $19,609,420 | $18,841,720 | $16,689,800 | $16,580,710 |
| Total Assets | $41,018,010 | $36,028,600 | $34,161,990 | $32,855,710 | $31,306,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 918,823 | 180,269 | 207,586 | 248,005 | 179,608 |
| Accounts payable and accrued liabilities | 2,598,827 | 1,448,205 | 2,207,119 | 1,124,343 | 2,095,522 |
| Other current liabilities | 17,959,200 | 16,513,570 | 13,706,310 | 15,250,610 | 12,841,690 |
| TOTAL | $22,881,890 | $19,015,580 | $17,125,100 | $17,623,770 | $15,680,670 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,836,531 | 3,496,875 | 3,443,429 | 3,265,601 | 3,457,454 |
| aiOther Non-Current Liabilities | 967,182 | 871,517 | 772,003 | 828,442 | 775,918 |
| TOTAL | $4,918,018 | $5,503,179 | $5,215,270 | $4,857,135 | $4,979,403 |
| Total Liabilities | $27,799,910 | $24,518,760 | $22,340,370 | $22,480,910 | $20,660,070 |
| Shareholders' Equity | |||||
| Common Shares | 65,891 | 65,710 | 64,570 | 61,697 | 65,208 |
| Retained earnings | 12,874,040 | 11,105,790 | 11,411,120 | 9,967,957 | 10,462,740 |
| Other shareholders' equity | 278,179 | 339,340 | 346,930 | 346,146 | 118,692 |
| TOTAL | $13,218,110 | $11,509,840 | $11,821,620 | $10,374,800 | $10,646,640 |
| Total Liabilities And Equity | $41,018,020 | $36,028,600 | $34,161,990 | $32,855,710 | $31,306,710 |